Fremanezumab 225mg/1.5ml solution for injection pre-filled disposable devices
NHS hospitals in England used £39,047,400 of indicative cost of Fremanezumab 225mg/1.5ml solution for injection pre-filled disposable devices in the 12 months to July 2026, about 0.2% of all hospital medicines spend. That is up 12.8% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Fremanezumab 225mg/1.5ml solution for injection pre-filled disposable devices: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Fremanezumab 225mg/1.5ml solution for injection pre-filled disposable devices most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Walton Centre Nhs Foundation Trust | £6,753,150 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £2,208,600 |
| University Hpls North Midlands Nhs Trust | £1,958,400 |
| King's College Hpl Nhs Foundation Trust | £1,567,800 |
| Royal Berkshire Nhs Foundation Trust | £1,376,100 |
| St George's Univ Hosps Foundation Nhst | £1,334,250 |
| Salford Royal Nhs Foundation Trust | £1,195,650 |
| Guy's & St Thomas' Nhs Foundation Trust | £1,125,900 |
| Hampshire Hospitals Nhs Foundation Trust | £1,103,400 |
| Lancashire T/Ing Hsp Nhs Foundation Trus | £1,073,700 |
The primary-care picture
Fremanezumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Fremanezumab medicine page.